Zankiren

DB20787ExperimentalSmall molecule

Zankiren is a small molecule drug. The usage of the INN stem '-kiren' in the name indicates that Zankiren is a renin inhibitor. Zankiren has a monoisotopic molecular weight of...

Formula / weight: C₃₅H₅₅N₅O₆S₂ · 705.97 g/mol (avg)

Resolves to

Compound

UNIII36B16A34QCAS138742-43-5ChEMBLCHEMBL113841ChEBI748474PubChem3086652

Structure

InChIKeyYFDSDRDMDDGDFC-HOQQKOLYSA-NSMILESCC(C)C[C@H](O)[C@H](O)[C@H](CC1CCCCC1)NC(=O)[C@H](CC1=CSC=N1)NC(=O)[C@H](CC1=CC=CC=C1)CS(=O)(=O)N1CCN(C)CC1

Targets

P00797REN

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Zankiren, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account